Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories.

作者: Jeffrey C. Hageman , Scott K. Fridkin , Jasmine M. Mohammed , Christine D. Steward , Robert P. Gaynes

DOI: 10.1086/502214

关键词:

摘要: Objective:The National Nosocomial Infections Surveillance (NNIS) System personnel report trends in antimicrobial-resistant pathogens. To validate select antimicrobial susceptibility testing results and to identify test methods that tend produce errors, we conducted proficiency among NNIS hospital laboratories.Setting:NNIS laboratories the United States.Methods:Each laboratory received five organisms (ie, an imipenem-resistant Serratia marcescens, oxacillin-resistant Staphylococcus aureus, a vancomycin-resistant Enterococcus faecalis, vancomycin-intermediate epidermidis, extended-spectrum beta-lactamase (ESβL)-producing Klebsiella pneumoniae). Testing were compared with reference from Centers for Disease Control Prevention.Results:Of 138 imipenem against marcescens strain, 110 (80%) correctly reported minimum inhibitory concentrations (MICs) or zone sizes resistant range. All 193 participating aureus strain as oxacillin resistant. Of laboratories, 169 (88%) correct MICs faecalis. One hundred sixty-two (84%) of demonstrated ability detect epidermidis; however, disk diffusion performed poorly when both staphylococci enterococci vancomycin. Although nonsusceptible cephalosporins aztreonam K. pneumoniae, only 98 (51%) this organism ESβL producer.Conclusion:Overall, detected most emerging resistance patterns. Disk continues be unreliable vancomycin must used cautiously enterococci. Further education on processing ESβL-producing is warranted.

参考文章(31)
T. Chou, R. Carey, M. A. Khurshid, C. Conover, S. L. Bornstein, R. Larsen, Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. Morbidity and Mortality Weekly Report. ,vol. 48, pp. 1165- 1167 ,(2000)
Erika Bruck, National Committee for Clinical Laboratory Standards. Pediatrics. ,vol. 65, pp. 187- 188 ,(1980)
F C Tenover, J Tokars, J Swenson, S Paul, K Spitalny, W Jarvis, Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. Journal of Clinical Microbiology. ,vol. 31, pp. 1695- 1699 ,(1993) , 10.1128/JCM.31.7.1695-1699.1993
R Grist, External factors affecting imipenem performance in dried microdilution MIC plates. Journal of Clinical Microbiology. ,vol. 30, pp. 535- 536 ,(1992) , 10.1128/JCM.30.2.535-536.1992
R L White, M B Kays, L V Friedrich, E W Brown, J R Koonce, Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. Journal of Clinical Microbiology. ,vol. 29, pp. 398- 400 ,(1991) , 10.1128/JCM.29.2.398-400.1991
Scott K. Fridkin, Robert P. Gaynes, ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITS Clinics in Chest Medicine. ,vol. 20, pp. 303- 316 ,(1999) , 10.1016/S0272-5231(05)70143-X
Benjamin Schwartz, Preventing the Emergence of Antimicrobial Resistance JAMA. ,vol. 278, pp. 944- 945 ,(1997) , 10.1001/JAMA.1997.03550110082041
John E. McGowan, Fred C. Tenover, Control of antimicrobial resistance in the health care system. Infectious Disease Clinics of North America. ,vol. 11, pp. 297- 311 ,(1997) , 10.1016/S0891-5520(05)70357-3